| Literature DB >> 16939758 |
Rosario Carpizo1, Angeles Martínez, Dolores Mediavilla, Mónica González, Araceli Abad, Emilio J Sánchez-Barceló.
Abstract
This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16939758 DOI： 10.1016/j.jpeds.2006.04.055
Source DB: PubMed Journal: J Pediatr ISSN： 0022-3476 Impact factor: 4.406